Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network

Barbara Mantoan; Elisa Genuardi; Martina Ferrante; Irene Della Starza; Elena Ciabatti; Susanna Grassi; Lucia Anna De Novi; Marzia Cavalli; Claudia Mannu; Anna Gazzola; Riccardo Bomben; Massimo Degan; Beatrice Alessandria; Christiane Pott; Marie Hélène Delfau-Larue; Ramon García-Sanz; Claudio Agostinelli; Valter Gattei; Sara Galimberti; Ilaria Del Giudice; Gianluca Gaidano; Marco Ladetto; Simone Ferrero; Daniela Drandi

doi:10.1097/HS9.0000000000000639

Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network

Barbara Mantoan, Elisa Genuardi, Martina Ferrante, Irene Della Starza, Elena Ciabatti, Susanna Grassi, Lucia Anna De Novi, Marzia Cavalli, Claudia Mannu, Anna Gazzola, Riccardo Bomben, Massimo Degan, Beatrice Alessandria, Christiane Pott, Marie Hélène Delfau-Larue, Ramon García-Sanz, Claudio Agostinelli, Valter Gattei, Sara Galimberti, Ilaria Del GiudiceGianluca Gaidano, Marco Ladetto, Simone Ferrero, Daniela Drandi

Department of Translational Medicine

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	E639
Journal	HemaSphere
Volume	5
Issue number	10
DOIs	https://doi.org/10.1097/HS9.0000000000000639
Publication status	Published - 6 Oct 2021

Access to Document

10.1097/HS9.0000000000000639

Cite this

Mantoan, B., Genuardi, E., Ferrante, M., Della Starza, I., Ciabatti, E., Grassi, S., De Novi, L. A., Cavalli, M., Mannu, C., Gazzola, A., Bomben, R., Degan, M., Alessandria, B., Pott, C., Delfau-Larue, M. H., García-Sanz, R., Agostinelli, C., Gattei, V., Galimberti, S., ... Drandi, D. (2021). Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network. HemaSphere, 5(10), E639. https://doi.org/10.1097/HS9.0000000000000639

@article{c50b8979bf844448a50edcb72d10b688,

title = "Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network",

author = "Barbara Mantoan and Elisa Genuardi and Martina Ferrante and {Della Starza}, Irene and Elena Ciabatti and Susanna Grassi and {De Novi}, {Lucia Anna} and Marzia Cavalli and Claudia Mannu and Anna Gazzola and Riccardo Bomben and Massimo Degan and Beatrice Alessandria and Christiane Pott and Delfau-Larue, {Marie H{\'e}l{\`e}ne} and Ramon Garc{\'i}a-Sanz and Claudio Agostinelli and Valter Gattei and Sara Galimberti and {Del Giudice}, Ilaria and Gianluca Gaidano and Marco Ladetto and Simone Ferrero and Daniela Drandi",

note = "Funding Information: This study was supported by Fondi di Ricerca Locale, Universit{\`a} degli Studi di Torino, Italy, and Fondazione CRT (projects code: 2018.1284), Turin, Italy.",

year = "2021",

month = oct,

day = "6",

doi = "10.1097/HS9.0000000000000639",

language = "English",

volume = "5",

pages = "E639",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "Wolters Kluwer Health",

number = "10",

}

Mantoan, B, Genuardi, E, Ferrante, M, Della Starza, I, Ciabatti, E, Grassi, S, De Novi, LA, Cavalli, M, Mannu, C, Gazzola, A, Bomben, R, Degan, M, Alessandria, B, Pott, C, Delfau-Larue, MH, García-Sanz, R, Agostinelli, C, Gattei, V, Galimberti, S, Del Giudice, I, Gaidano, G , Ladetto, M, Ferrero, S & Drandi, D 2021, 'Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network', HemaSphere, vol. 5, no. 10, pp. E639. https://doi.org/10.1097/HS9.0000000000000639

TY - JOUR

T1 - Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma

T2 - 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network

AU - Mantoan, Barbara

AU - Genuardi, Elisa

AU - Ferrante, Martina

AU - Della Starza, Irene

AU - Ciabatti, Elena

AU - Grassi, Susanna

AU - De Novi, Lucia Anna

AU - Cavalli, Marzia

AU - Mannu, Claudia

AU - Gazzola, Anna

AU - Bomben, Riccardo

AU - Degan, Massimo

AU - Alessandria, Beatrice

AU - Pott, Christiane

AU - Delfau-Larue, Marie Hélène

AU - García-Sanz, Ramon

AU - Agostinelli, Claudio

AU - Gattei, Valter

AU - Galimberti, Sara

AU - Del Giudice, Ilaria

AU - Gaidano, Gianluca

AU - Ladetto, Marco

AU - Ferrero, Simone

AU - Drandi, Daniela

N1 - Funding Information: This study was supported by Fondi di Ricerca Locale, Università degli Studi di Torino, Italy, and Fondazione CRT (projects code: 2018.1284), Turin, Italy.

PY - 2021/10/6

Y1 - 2021/10/6

UR - http://www.scopus.com/inward/record.url?scp=85118134371&partnerID=8YFLogxK

U2 - 10.1097/HS9.0000000000000639

DO - 10.1097/HS9.0000000000000639

M3 - Letter

SN - 2572-9241

VL - 5

SP - E639

JO - HemaSphere

JF - HemaSphere

IS - 10

ER -

Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network

Access to Document

Other files and links

Cite this